A NOVEL SENOLYTIC NANOFORMULATION TARGETING THE HEPATIC SINUSOID IMPROVES HEPATIC FUNCTION AND FIBROSIS IN EXPERIMENTAL MODELS OF AGING

被引：0

作者：

Sanfeliu-Redondo, David ^{[1
]}

Francisco, Vitor ^{[2
]}

Tome, Ines ^{[2
,3
]}

Marques, Andreia ^{[2
,4
]}

Aristu, Peio ^{[1
,5
]}

Pitrez, Joao ^{[2
,6
]}

Rosa, Susana ^{[2
]}

Ferreira, Lino ^{[2
,4
]}

Gracia-Sancho, Jordi ^{[1
,7
]}

机构：

[1] Hosp Clin Barcelona, Idibaps, Ciberehd, Barcelona, Spain

[2] Univ Coimbra, Cnc Ctr Neurosci & Cell Biol, Coimbra, Portugal

[3] Univ Coimbra, Fac Pharm, Coimbra, Portugal

[4] Univ Coimbra, Fac Med, Coimbra, Portugal

[5] BLB, Barcelona, Spain

[6] Inst Super Engn Coimbra, Coimbra, Portugal

[7] Univ Bern, Inselspital, Bern, Switzerland

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2614-A

引用

页码：S1256 / S1257

页数：2

共 50 条

[21] When is a Kupffer cell not a Kupffer cell? Novel insight into macrophage fate and function in hepatic fibrosis
Arteel, Gavin E.
JOURNAL OF LEUKOCYTE BIOLOGY, 2024, 115 (03) : 415 - 416
[22] INHIBITION OF THE LYSOPHOSPHATIDIC ACID PATHWAY IMPROVES HEPATIC FIBROSIS AND PORTAL HYPERTENSION IN EXPERIMENTAL ADVANCED CHRONIC LIVER DISEASE
Aristu, Peio
Boyer-Diaz, Zoe
Zagorska, Anna
Sharma, Monika
Andres-Rozas, Maria
Budas, Grant
Bosch, Jaime
Gracia-Sancho, Jordi
HEPATOLOGY, 2023, 78 : S1201 - S1202
[23] Reduction of hepatic fibrosis by overexpression of von Hippel–Lindau protein in experimental models of chronic liver disease
Jizhou Wang
Zhaoyang Lu
Zhilin Xu
Pei Tian
Hui Miao
Shangha Pan
Ruipeng Song
Xueying Sun
Baolei Zhao
Dawei Wang
Yong Ma
Xuan Song
Shugeng Zhang
Lianxin Liu
Hongchi Jiang
Scientific Reports, 7
[24] Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
Boyer-Diaz, Zoe
Aristu-Zabalza, Peio
Andres-Rozas, Maria
Robert, Claude
Ortega-Ribera, Marti
Fernandez-Iglesias, Anabel
Broqua, Pierre
Junien, Jean-Louis
Wettstein, Guillaume
Bosch, Jaime
Gracia-Sancho, Jordi
JOURNAL OF HEPATOLOGY, 2021, 74 (05) : 1188 - 1199
[25] THE PAN-PPAR AGONIST LANIFIBRANOR IMPROVES PORTAL HYPERTENSION AND HEPATIC FIBROSIS IN EXPERIMENTAL ADVANCED CHRONIC LIVER DISEASE
Aristu, Peio
Boyer-Diaz, Zoe
Broqua, Pierre
Junien, Jean-Louis
Wettstein, Guillaume
Bosch, Jaime
Gracia-Sancho, Jordi
HEPATOLOGY, 2019, 70 : 44A - 45A
[26] The Slc25a47 locus is a novel determinant of hepatic mitochondrial function implicated in liver fibrosis
Bresciani, Nadia
Demagny, Hadrien
Lemos, Vera
Pontanari, Francesca
Li, Xiaoxu
Sun, Yu
Li, Hao
Perino, Alessia
Auwerx, Johan
Schoonjans, Kristina
JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 1071 - 1082
[27] RNA interference targeting the platelet-derived growth factor receptor β subunit ameliorates experimental hepatic fibrosis in rats
Chen, Si-Wen
Zhang, Xing-Rong
Wang, Chong-Ze
Chen, Wei-Zhong
Xie, Wei-Fen
Chen, Yue-Xiang
LIVER INTERNATIONAL, 2008, 28 (10) : 1446 - 1457
[28] MicroRNA-19b Reduces Hepatic Stellate Cell Proliferation by Targeting GRB2 in Hepatic Fibrosis Models In Vivo and In Vitro as Part of the Inhibitory Effect of Estradiol
Ge, Shanfei
Xie, Jianping
Liu, Fei
He, Jinni
He, Jinwen
JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (11) : 2455 - 2464
[29] Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease
Wang, Jizhou
Lu, Zhaoyang
Xu, Zhilin
Tian, Pei
Miao, Hui
Pan, Shangha
Song, Ruipeng
Sun, Xueying
Zhao, Baolei
Wang, Dawei
Ma, Yong
Song, Xuan
Zhang, Shugeng
Liu, Lianxin
Jiang, Hongchi
SCIENTIFIC REPORTS, 2017, 7
[30] Clarifying the Role of Hepatic Stellate Cells in Age-Related Liver Fibrosis by Their Depletion in Novel Murine Models
Chiu, S.
Carter, J.
Parvin-Nejad, F.
Lee, Y.
Friedman, S.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S297 - S297

← 1 2 3 4 5 →